Cutaneous Squamous Cell Carcinoma — Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC)
Citation(s)
Phase Ib/II Study of Micro-needle Array Containing Doxorubicin in Immune Competent or Immune-suppressed Patients With Cutaneous Squamous Cell Carcinoma